Vaxart (VXRT) has the following price history information. Looking back at VXRT historical stock prices for the last five trading days, on April 23, 2024, VXRT opened at $0.77, traded as high as $0.82 and as low as $0.71, and closed at $0.75. Trading volume was a total of 1.59M shares. On April 24, 2024, VXRT opened at $0.76, traded as high as $0.76 and as low as $0.70, and closed at $0.71. Trading volume was a total of 1.46M shares. On April 25, 2024, VXRT opened at $0.70, traded as high as $0.72 and as low as $0.63, and closed at $0.66. Trading volume was a total of 1.94M shares. On April 26, 2024, VXRT opened at $0.70, traded as high as $0.71 and as low as $0.66, and closed at $0.71. Trading volume was a total of 1.32M shares. On April 29, 2024, VXRT opened at $0.71, traded as high as $0.75 and as low as $0.70, and closed at $0.71. Trading volume was a total of 991.80K shares.

VXRT Historical Stock Prices By Date:

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 20142015201620172018201920202021202220232024

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Vaxart shares, starting with a $10,000 purchase of VXRT, and working forward through the historical stock price information to today.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	05/01/2014
End date:	04/29/2024
Start price/share:	$40.37
End price/share:	$0.71
Dividends collected/share:	$0.00
Total return:	-98.24%
Average Annual Total Return:	-33.23%
Starting investment:	$10,000.00
Ending investment:	$175.93
Years:	10.00

VXRT Historical Price Range
Date	Open	High	Low	Close	Volume
04/23/2024	$0.77	$0.82	$0.71	$0.75	1.59M
04/24/2024	$0.76	$0.76	$0.70	$0.71	1.46M
04/25/2024	$0.70	$0.72	$0.63	$0.66	1.94M
04/26/2024	$0.70	$0.71	$0.66	$0.71	1.32M
04/29/2024	$0.71	$0.75	$0.70	$0.71	991.80K

About Vaxart

Vaxart is a clinical-stage biotechnology company primarily focused on the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology proprietary oral vaccine platform. Co.'s oral vaccines are designed to generate immune responses that protect against a range of infectious diseases and may be useful for the treatment of chronic viral infections and cancer. Co.'s investigational vaccines are administered using a room temperature-stable tablet, rather than by injection. In addition, Co. is in early development of its first therapeutic vaccine targeting cervical cancer and dysplasia caused by human papillomavirus.

VXRT Historical Closing Prices
Date	Close
04/23/2024	$0.75
04/24/2024	$0.71
04/25/2024	$0.66
04/26/2024	$0.71
04/29/2024	$0.71

VXRT Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.